Related Experiment Video
Updated: Jan 18, 2026
Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
Published on: December 20, 2024
Impact of Chronic Rhinosinusitis on Long-Term Clinical Outcomes in Adults With Asthma
Seong-Dae Woo1, Jieun Seo2, You-Seob Shin2
1Department of Pulmonary, Allergy, and Critical Care Medicine, Chungnam National University School of Medicine, Daejeon, South Korea.
Background:
Chronic rhinosinusitis (CRS) is a common comorbidity affecting clinical outcomes in adults with asthma.
Objective:
To assess the impact of CRS on long-term asthma outcomes in a real-world clinical setting.
Methods:
This retrospective cohort study analyzed the medical records of 16,153 adults with asthma at the Ajou University Medical Center, Korea. Patients were classified into those with and without comorbid CRS. The CRS group was further stratified into the type 2 (T2)-high and T2-low CRS subgroups based on blood eosinophil counts. Over a 10-year follow-up, long-term clinical outcomes, including asthma exacerbation (AE), hospitalization or emergency department (ED) visits, and systemic corticosteroid use, were estimated using Kaplan-Meier curves and Cox proportional hazards models. We analyzed longitudinal laboratory and lung function measures using adjusted linear mixed-effects models.
Results:
After propensity score matching, we performed between-group comparisons. The CRS group had higher risks of severe AE (hazard ratio [HR] = 2.07; 95% CI, 1.51-2.87), overall AE (HR = 1.59; 95% CI, 1.36-1.86), hospitalization or ED visits (HR = 1.38; 95% CI, 1.08-1.78), and systemic corticosteroid use (HR = 1.44; 95% CI, 1.25-1.66). Further, these risks were persistently higher in the T2-high CRS subgroup than in the T2-low CRS subgroup (P < .001 for all). Throughout the follow-up, the CRS group, particularly the T2-high subgroup, exhibited elevated blood or sputum eosinophils and FeNO levels, with greater lung function decline than in the non-CRS or T2-low CRS subgroups.
Conclusion:
Comorbid CRS, particularly a T2-high CRS endotype, is associated with increased 10-year risk of AEs, hospitalizations or ED visits, and systemic corticosteroid use, as well as greater lung function decline in adults with asthma.
Related Concept Videos
01:24Asthma-III: Symptoms and Complications
Classification of Asthma
01:29Asthma-I: Introduction
01:20Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:26Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
01:23Chronic Pharyngitis
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...